FDA Inspection 1268339 — Marcus Lages
The FDA completed an inspection of Marcus Lages on April 2, 2025 in Cockeysville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 2, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Cockeysville, MD (United States)